{"name":"Novatek Pharmaceuticals","slug":"novatek-pharmaceuticals","ticker":"","exchange":"","domain":"","description":"Novatek Pharmaceuticals is a biopharmaceutical company focused on developing innovative treatments in the early stages of clinical development. With a pipeline of two drugs currently in Phase 2 trials, the company aims to address significant unmet medical needs.","hq":"","founded":0,"employees":"N/A","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxOcWo0NHYycURBMW5xMHlma0hfRWg5TGVqN29DZmZ5Q1JaZi1oOU9HYlptLV9PZndJVER5U3duVXduSm4yVHloS25IRS1GeTc4M21iYm1YbEtyeDY5N2VibU9GMUt5bFMtTWpsNWhyLWx3SF9LNEdsRHdDZG9tVEppUXI1ZmFUeUFESlJNZ1FKVEMxcnhSa0FmdTMzdEJNb0ZseUpiRkZFY0Y5UGY0SFVj?oc=5","date":"2026-01-17","type":"pipeline","source":"Theinvestor","summary":"Chinese firm Livzon eyes nearly 78% stake in Vietnam's pharma major Imexpharm - Theinvestor","headline":"Chinese firm Livzon eyes nearly 78% stake in Vietnam's pharma major Imexpharm","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxNTUQ5OFg0d0dnVlFNeVFYOEV4ZlMwY1dIbXl5V2pNVWdJUXVSWURIT0V1Q09pX0t2VGhPREtXelR5dDhtM3o1WFc1UTJsdmhlWXZJMU5QYWd0aF9MTU4zYWp5Tno0UXdVUm9lY3Z0OVJzQ2pQSGpNYkljaWxiOWFtUzU5aGtnU0VlMkRRZlV4d3dUZmJTOFRNY1RodGFZNGw4SXpjQ9IBqgFBVV95cUxQVzVydU9RczdIcXE4UEtOMHlNeWZQWVFVY285YjJ3LVR0NnV1ZnpCbjl4bWpvcEh0S0QzbmVTQWstUjIyUzktZy1fRG9zczJkTzN3eXZyNnhZNl9IOXY1ckdRZlpMTTZNdE5aSURZdGhsbE05T1RXWGk2VjJTRGpuSF9Ua2pvRS1ELTFBY2JrSXJnaThvMFR4Uk5PZjd0MTlGNkVyTmhJRlV1QQ?oc=5","date":"2025-10-26","type":"pipeline","source":"The Business Standard","summary":"442 types of pharma raw materials destroyed in Dhaka airport fire - The Business Standard","headline":"442 types of pharma raw materials destroyed in Dhaka airport fire","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiswJBVV95cUxPN0hNQkNaSE5SbGtYTDRNbmY4OWV3ODJlb1ZFZW1jWW5zSklGWEtDOS1mYUJFUHdWMGxyLTN2ZDR4aFB2c0tLNnFRQ2lZTGJ6aGViRWRWT0lPRVctLVBGYzEzdFU5RTFsLWtoUW1CU2ZqUkMzQnFNVTk3bmxZZWhCQnhaMW1wdkhrSENYWC1VaUQ2a1V1NW1CYWJMbmhpUU1TenY3NjVRWW5JZUF3d25WaDZKZmhQMVN2UjF6RTluaUY4dVJGelo3N2huRlJ2b1BKRHpIVXltc3dLODNPNkt0bGN3RGg4WGdtTjU4QUdDNm9rTGhtVVd3SjB1QzdPemNKbXMzV3pSN19handVUjgzN0laVVpQNFF2N2p4dWtvcE8zd01hZmJzekZvMDA4YkVjNFlB?oc=5","date":"2024-07-09","type":"pipeline","source":"PR Newswire","summary":"Radioligand Therapies Market to Show Immense Growth by 2034, Predicts DelveInsight | Key Companies - Curium US, Eli Lilly, Point Biopharma, Fusion, Astrazeneca - PR Newswire","headline":"Radioligand Therapies Market to Show Immense Growth by 2034, Predicts DelveInsight | Key Companies - Curium US, Eli Lill","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}